Philip Probert | Technology Lead
CPI

Dr. Philip Probert is a strategic scientific leader with extensive experience in bioprocessing and strategy development. He currently serves as Biologics Technology Lead at CPI, where he heads up the development department, delivering a diverse portfolio of innovation projects focused on the development and scale-up of biologic therapeutics and vaccines. His expertise spans all biologic modalities, with particular subject expertise in synthetic and cell free manufacturing processes for nucleic acids and proteins. Dr. Probert holds a PhD in Hepatic Toxicology from Newcastle University and an MBA from the Open University.